Literature DB >> 30983040

Antibiotic therapy as personalized medicine - general considerations and complicating factors.

Claus Moser1,2, Christian Johann Lerche1, Kim Thomsen1, Tom Hartvig2, Jens Schierbeck3, Peter Østrup Jensen1,2, Oana Ciofu4, Niels Høiby1,4.   

Abstract

The discovery of antibiotic drugs is considered one of the previous century's most important medical discoveries (Medicine's 10 greatest discoveries. New Haven, CT: Yale University Press, 1998: 263). Appropriate use of antibiotics saves millions of lives each year and prevents infectious complications for numerous people. Still, infections kill unacceptable many people around the world, even in developed countries with easy access to most antibiotic drugs. Optimal use of antibiotics is dependent on the identification of primary and secondary focus, and knowledge on which pathogens to expect in a specific infectious syndrome and information on general patterns of regional antibiotic resistance. Furthermore, sampling for microbiological analysis, knowledge of patient immune status and organ functions, travel history, pharmacokinetics and -dynamics of the different antibiotics and possible biofilm formation are among several factors involved in antibiotic therapy of infectious diseases. The present review aims at describing important considerations when using antibacterial antibiotics and to describe how this is becoming substantially more personalized. The parameters relevant in considering the optimal use of antibiotics to treat infections are shown in Fig. 1 - leading to the most relevant antibiotic therapy for that specific patient. To illustrate this subject, the present review's focus will be on challenges with optimal dosing of antibiotics and risks of underdosing. Especially, in cases highly challenging for achieving the aimed antibiotic effect against bacterial infections - this includes augmented renal clearance (ARC) in sepsis, dosing challenges of antibiotics in pregnancy and against biofilm infections.
© 2019 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Antibiotics; augmented renal clearance; biofilm infections; pharmacodynamics; pharmacokinetics; precision medicine; sepsis

Mesh:

Substances:

Year:  2019        PMID: 30983040     DOI: 10.1111/apm.12951

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  15 in total

1.  Inappropriate use of antibiotics and its predictors in pediatric patients admitted at the Central Hospital of Nampula, Mozambique.

Authors:  Sancho Pedro Xavier; Audêncio Victor; Graciano Cumaquela; Melsequisete Daniel Vasco; Osiyallê Akanni Silva Rodrigues
Journal:  Antimicrob Resist Infect Control       Date:  2022-06-02       Impact factor: 6.454

2.  Prevalence of biofilms in acute infections challenges a longstanding paradigm.

Authors:  Mette Kolpen; Peter Østrup Jensen; Daniel Faurholt-Jepsen; Thomas Bjarnsholt
Journal:  Biofilm       Date:  2022-06-09

3.  Evaluation of current dosing guidance for oral rifampicin treatment in adult patients with osteoarticular infections.

Authors:  Amélie Marsot; Amélie Ménard; Julien Dupouey; Laurent Allanioux; Olivier Blin; Romain Guilhaumou
Journal:  Br J Clin Pharmacol       Date:  2020-05-13       Impact factor: 4.335

4.  Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential.

Authors:  Yaoqiang Shi; Chao Li; Mei Wang; Zijun Chen; Ying Luo; Xue-Shan Xia; Yuzhu Song; Yi Sun; A-Mei Zhang
Journal:  ACS Omega       Date:  2020-04-14

Review 5.  Nine Things Genomics Can Tell Us About Candida auris.

Authors:  Aleksandra D Chybowska; Delma S Childers; Rhys A Farrer
Journal:  Front Genet       Date:  2020-04-15       Impact factor: 4.599

6.  Cereus sinensis Polysaccharide Alleviates Antibiotic-Associated Diarrhea Based on Modulating the Gut Microbiota in C57BL/6 Mice.

Authors:  Mingxiao Cui; Yu Wang; Jeevithan Elango; Junwen Wu; Kehai Liu; Yinzhe Jin
Journal:  Front Nutr       Date:  2021-12-13

Review 7.  Harnessing the Potential of Multiomics Studies for Precision Medicine in Infectious Disease.

Authors:  Rebecca A Ward; Nima Aghaeepour; Roby P Bhattacharyya; Clary B Clish; Brice Gaudillière; Nir Hacohen; Michael K Mansour; Philip A Mudd; Shravani Pasupneti; Rachel M Presti; Eugene P Rhee; Pritha Sen; Andrej Spec; Jenny M Tam; Alexandra-Chloé Villani; Ann E Woolley; Joe L Hsu; Jatin M Vyas
Journal:  Open Forum Infect Dis       Date:  2021-09-25       Impact factor: 3.835

8.  Relationships Between Diagnosis, Bacterial Isolation, and Antibiotic Prescription in Out Patients With Respiratory Tract Infection Symptoms in Rural Anhui, China.

Authors:  Shen Xingrong; Feng Rui; Chai Jing; Cheng Jing; Isabel Oliver; Helen Lambert; Debin Wang
Journal:  Front Public Health       Date:  2022-02-09

9.  Effect of augmented renal clearance on the therapeutic drug monitoring of vancomycin in patients after neurosurgery.

Authors:  Yue Chen; Lei Liu; Man Zhu
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

Review 10.  Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections.

Authors:  Isabelle Bekeredjian-Ding
Journal:  Front Immunol       Date:  2020-08-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.